LB

Lexington Blood

Venture Partner at 7BC.VC

Park City, Utah

Overview 

Lexington Blood is a General Partner with experience in hedge funds, venture capital, fintech, and biotech industries. With a background in entrepreneurship and product development, he has held advisory and leadership roles in notable organizations like Takara, Quantitative Hedge Fund, and Joinery Biosciences. Blood's career highlights include serving as a General Partner at a quantitative hedge fund and co-founding Joinery Biosciences, showcasing his expertise in strategic investments and biotech startups. Currently, he is actively involved in advising and partnering with companies in the pharmaceuticals, biotech, and AI sectors through his roles as a Venture Partner at 7BC.VC and as a Senior Financial Advisor at the Office of H.H. Sheikh Ahmed Al-Qassimi.

Work Experience 

  • General Partner

    2017 - Current

    US registered hedge fund, quant fund, public & private equity. Liquidity focused asset management. Obsessively serving accredited and institutional investors: Family Office, Multi Family Office, UNHW, LP, Entrepreneurs, Business Owners, Institutional Investors, Pension Funds, Endowment Funds, Banks, Corporate Treasury, Corporate Venture Capital, Trust Funds, Insurance Funds. #Equities #Futures #S&PP500 #Nasdaq #T-Notes #Stocks #Commodities #Currencies #Bonds #Options #PE #Credit #Derivatives #Equities #HFT #Long / Short #StockMarket #HedgeFund #Quant #AI #Trading #InvestmentManagement #assetmanagement #FamilyOffice #UNHW #LP #Entrepreneurs #BusinessOwners #InstitutionalInvestors #PensionFunds #EndowmentFunds #Banks #CorporateTreasury #MultiFamilyOffice #CorporateVentureCapital #TrustFunds #InsuranceFunds #QuantitativeInvestment #QuantFund #StockTrading

  • Venture Partner

    2018

    Global venture capital fund & fund of funds: 3 ways we support the augmented intelligence era: 1- Direct investments via 7BC Fund IV. 2- Fund of funds backing great Venture Capitalists. 3- SPV for one-off opportunities. Fund IV USA and Fund V Saudi Arabia are now live actively fundraising and investing. Thesis: Revenue $1M+ growing fast. Merit based. Our best guess predicated on qualitative and quantitative data. https://7bc.vc

  • Cofounder

    2020

    AI evolutionary algorithmic in silico discovery, synthesis, and validation of custom macromolecules to modify protein-protein interactions. https://www.joinerybio.com/ 1- Discover/Design 2- Screen/Validate 3- Manufacture Support biotech and pharma companies developing diagnostics and therapeutics with efficient small molecule validation and protein engineering. We have developed a mature evolutionary algorithm to quickly design, screen, and optimize antibodies, aptamers, and other biosensors at a fraction of the cost of high-throughput screening. We can also manufacture the final product antibodies and/or proteins at scale. We use a novel generative approach to rationally design de novo peptides and ‘mini’ proteins. Examples include development of PPI modulators for cancer, diabetes, autoimmune disorders, and infectious diseases.

  • Cofounder

    2020

    End-to-End prototyping design R&D engineering nanofabrication and high volume automated robotic manufacturing of diagnostics and sophisticated commercial devices. Contract Manufacturer. https://www.utahnanoplate.com

  • Investment Advisor / Family Office

    2022

    Family Office of His Highness Sheikh Ahmed Al-Qassimi, a UAE royal family member and diplomat currently invested in a wide variety of industries in public and private partnerships with governments in over 27 countries and counting around the globe.

  • Board Advisor

    2023

    ZOTH brings Global Defi liquidity to solve the $5 Trillion Credit gap in emerging markets for SME's & Startups while providing market beating fixed income for its investors Part of Foundership Accelerator Top 5 Defi Project in Hypernest by Polygon Part of Stellar Bootcamp Backed by Graviton, SOSV & Super Angels.

  • Board Advisor

    2024

  • Advisor

    2023

    SiliconMint provides dedicated software teams that architect, build and support mission-critical systems. We set ourselves apart by the technical depth and breadth of our engineering staff. With offices in San Francisco, New York, and Europe, we deliver innovative solutions worldwide. WHAT WE SPECIALIZE IN: ∙ Custom software development (.NET, Java, C#, C++, React, Angular, Vue.js, Node.js, React Native, Python, Go, etc.) ∙ Embedded Systems & IoT ∙ AI, ML, Cognitive Computing and Computer Vision development ∙ Science-intensive software development ∙ Software project rescue ∙ Enterprise legacy systems migration, and much more. The power to create full-fledged applications is now in the hands of everyone with a spreadsheet. Create software at 7 - 10X the speed. See it in action: https://mintdata.com/intro - Create any user interface (UI) with the ease of Sketch / PowerPoint - Create logic with the familiarity of a spreadsheet - Construct visual flows to connect with external & internal company data - Publish resulting applications to mobile devices and the desktop web - Run on-premise / your cloud or the MintData cloud Customers we’ve helped in the past: * Verizon: scalable IoT cloud with real-time analytics for millions of households; * Yahoo Japan: 16x improvement in ad approval process. Want to see a demo? https://mintdata.com/showcase

  • Advisor

    2024

  • Cofounder

    2023 - 2024

    Upgrading Financial Institution's Assets Fintech company leveraging financial engineering through an end-to-end automated platform that unlocks value embedded in portfolios. Takara's first product measurably improves the profitability of Banks and Credit Unions lending portfolio by liquidating the gap between face value and market value on low fixed-rate mortgages. Our first-to-market solution upgrades assets into high-yield, lower-risk securities generating substantial profits without any loss recognition. *Meets all regulatory compliance laws for financial institutions.

  • Advisor / US Partner

    2019

    We at PeopleBio aim to help individuals approach a happier future through the early diagnosis and treatment of protein misfolding diseases. PeopleBio is a biotech company that focuses on developing technologies for the happiness of the people.

Articles About Lexington

Relevant Websites